Vitamin D inflammatory cytokines and coronary events: A comprehensive review

Clinical Reviews in Allergy and Immunology

Volumn 45, Issue 2, 2013, Pages 236-247

  Arnson, Yoav ^a,b   Itzhaky, Dganit ^b,c   Mosseri, Morris ^a,b   Barak, Vivian ^d   Tzur, Boaz ^b,e   Agmon Levin, Nancy ^b,e   Amital, Howard ^b,e  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Clalit Central Laboratory   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Acute myocardial infarction; Cytokines; IL 6; Inflammation; Tumor necrosis factor; Vascular endothelial growth factor; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VITAMIN D;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; CARDIOVASCULAR RISK; CELL INTERACTION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENDOTHELIUM CELL; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HEART PROTECTION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; ISCHEMIC HEART DISEASE; LEUKOCYTE; MALE; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; VITAMIN SUPPLEMENTATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; C-REACTIVE PROTEIN; CARDIAC CATHETERIZATION; CORONARY VESSELS; FEMALE; FINLAND; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84884907659     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8356-0     Document Type: Review

References (102)

1. Behar S, Battler A, Porath A, Leor J, Grossman E, Hasin Y, Mittelman M, Feigenberg Z, Rahima-Maoz C, Green M, Caspi A, Rabinowitz B, Garty M (2003) A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000. Isr Med Assoc J 5(4):249-254
2. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118(20):2057-2062
3. Jennings RB, Murry CE, Steenbergen C Jr, Reimer KA (1990) Development of cell injury in sustained acute ischemia. Circulation 82(3 Suppl):II2-II12
4. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML (1998) Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol 30(12):2567-2576
5. Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro CV, La Carrubba S, Carerj S, Turiel M (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8(4):281-286
6. Amital H, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Kiss E, Rovensky J, Tuchynova A, Kozakova D, Doria A, Corocher N, Agmon-Levin N, Barak V, Orbach H, Zandman-Goddard G, Shoenfeld Y (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69(6):1155-1157
7. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66(9):1137-1142
8. Arnson Y, Amital H, Agmon-Levin N, Alon D, Sanchez-Castanon M, Lopez-Hoyos M, Matucci-Cerinic M, Szucs G, Shapira Y, Szekanecz Z, Shoenfeld Y (2011) Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 10(8):490-494
9. Arnson Y, Amital H (2011) Is vitamin D a new therapeutic agent in autoinflammatory and pain syndromes? Isr Med Assoc J 13(4):234-235
10. Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W, Stojanovich L, Barak V, Porat-Katz BS, Amital H, Shoenfeld Y (2011) Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis 70(1):145-150
11. Agmon-Levin N, Kivity S, Tzioufas AG, Lopez-Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P, Shoenfeld Y (2012) Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. J Autoimmun 39:234-239
12. Holick MF (2007) Vitamin D, deficiency. N Engl J Med 357(3):266-281
13. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385-400
14. Shoenfeld N, Amital H, Shoenfeld Y (2009) The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 5(2):99-105
15. Twig G, Shina A, Amital H, Shoenfeld Y (2012) Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun 38(2-3):J275-J281
16. Antico A, Tozzoli R, Giavarina D, Tonutti E, Bizzaro N (2012) Hypovitaminosis d as predisposing factor for atrophic type a gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system. Clin Rev Allergy Immunol 42(3):355-364
17. Cutolo M, Pizzorni C, Sulli A (2011) Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev 11(2):84-87
18. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168(12):1340-1349
19. Gonzalez-Molero I, Rojo-Martinez G, Morcillo S, Gutierrez-Repiso C, Rubio-Martin E, Almaraz MC, Olveira G, Soriguer F (2012) Vitamin D and incidence of diabetes: a prospective cohort study. Clin Nutr 31(4):571-573
20. Holick MF (2012) The D-lightful vitamin D for child health. JPEN J Parenter Enter Nutr 36(1 Suppl):9S-19S
21. Lerner A, Shapira Y, Agmon-Levin N, Pacht A, Ben-Ami SD, Lopez-Hoyos M, Sanchez-Castanon M, Shoenfeld Y (2012) The clinical significance of 25OH-vitamin D status in celiac disease. Clin Rev Allergy Immunol 42(3):322-330
22. Lund B, Badskjaer J, Lund B, Soerensen OH (1978) Vitamin D and ischaemic heart disease. Horm Metab Res 10(6):553-556
23. Mutlu A, Mutlu GY, Ozsu E, Cizmecioglu FM, Hatun S (2011) Vitamin D deficiency in children and adolescents with type 1 diabetes. J Clin Res Pediatr Endocrinol 3(4):179-183
24. Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J (2011) Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 10(12):733-743
25. Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 9(7):507-510
26. Sadovnick AD (2012) Genetic background of multiple sclerosis. Autoimmun Rev 11(3):163-166
27. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83(4):754-759
28. 3 levels: a community-based study. Int J Epidemiol 19(3):559-563
29. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stuve O (2011) The increasing incidence and prevalence of female multiple sclerosis- A critical analysis of potential environmental factors. Autoimmun Rev 10(8):495-502
30. Vik B, Try K, Thelle DS, Forde OH (1979) Tromso Heart Study: vitamin D metabolism and myocardial infarction. Br Med J 2(6183):176
31. Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168(11):1174-1180
32. Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167(16):1730-1737
33. Gannage-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (2003) Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Investig 26(8):748-753
34. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126(16):2020-2035
35. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17(11):1391-1401
36. Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S, Carerj S, Turiel M (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8(4):281-286
37. Frangogiannis NG (2006) The mechanistic basis of infarct healing. Antioxid Redox Signal 8(11-12):1907-1939
38. Nathan C (2002) Points of control in inflammation. Nature 420(6917):846-852
39. Atzeni F, Turiel M, Caporali R, Cavagna L, Tomasoni L, Sitia S, Sarzi-Puttini P (2010) The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases. Autoimmun Rev 9(12):835-839
40. de Carvalho JF, Viana VS, Neto EF, Santos RD, Bonfa E (2011) Anti-lipoprotein lipase antibodies in patients with hypertriglyceridemia without associated autoimmune disease. Isr Med Assoc J 13(6):350-353
41. Liao YH, Fu M (2001) Autoimmunity in the pathogenesis of cardiomyopathy. J Autoimmun 16(1):1-2
42. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13(3):325-349
43. 3 receptors in human leukocytes. Science 221(4616):1181-1183
44. Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, Laureys J, Rutgeerts O, Saint-Arnaud R, Bouillon R, Mathieu C (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120(1):139-146
45. 3-mediated effects. J Immunol 160(1):209-218
46. Gouni-Berthold I, Krone W, Berthold HK (2009) Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 7(3):414-422
47. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30(10):2569-2570
48. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49(5):1063-1069
49. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF (2008) Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52(24):1949-1956
50. 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326(7387):469
51. 3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30(12):2495-2503
52. Meems LM, van der Harst P, van Gilst WH, de Boer RA (2011) Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr Drug Targets 12(1):29-41
53. Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Sillje HH, van Gilst WH, Jaarsma T, de Boer RA (2011) Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 13(6):619-625
54. Daskalopoulos EP, Janssen BJ, Blankesteijn WM (2012) Myofibroblasts in the infarct area: concepts and challenges. Microsc Microanal 18(1):35-49
55. Liehn EA, Postea O, Curaj A, Marx N (2011) Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol 58(23):2357-2362
56. Liu SQ, Tefft BJ, Zhang D, Roberts D, Schuster DJ, Wu A (2011) Cardioprotective mechanisms activated in response to myocardial ischemia. Mol Cell Biomech 8(4):319-338
57. Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A (2011) Angiogenic properties of the chemokine RANTES/CCL5. Biochem Soc Trans 39(6):1649-1653
58. van Kimmenade RR, Januzzi JL Jr (2012) Emerging biomarkers in heart failure. Clin Chem 58(1):127-138
59. Alwi I, Santoso T, Suyono S, Sutrisna B, Kresno SB (2007) The cut-off point of interleukin-6 level in acute coronary syndrome. Acta Med Indones 39(4):174-178
60. Maggio M, Guralnik JM, Longo DL, Ferrucci L (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61(6):575-584
61. Puhakka M, Magga J, Hietakorpi S, Penttila I, Uusimaa P, Risteli J, Peuhkurinen K (2003) Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail 9(4):325-332
62. Baumgarten G, Knuefermann P, Mann DL (2000) Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc Med 10(5):216-223
63. Edens HA, Parkos CA (2000) Modulation of epithelial and endothelial paracellular permeability by leukocytes. Adv Drug Deliv Rev 41(3):315-328
64. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML (1999) Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99(4):546-551
65. Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Spengler RN, Smith CW, Entman ML (1998) Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98(7):699-710
66. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL (1997) Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 81(2):187-195
67. Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86(12):1259-1265
68. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97(14):1382-1391
69. Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM (2000) Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci U S A 97(23):12746-12751
70. Pasqui AL, Di Renzo M, Maffei S, Pastorelli M, Pompella G, Auteri A, Puccetti L (2010) Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling. Mediat Inflamm 2010:974694
71. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94(5):874-877
72. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML (1995) Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92(7):1866-1875
73. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22(10):1668-1673
74. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI (2000) Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 14(15):2525-2531
75. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT (2004) IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 24(8):1503-1508
76. Jordan JE, Zhao ZQ, Vinten-Johansen J (1999) The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43(4):860-878
77. Kokura S, Wolf RE, Yoshikawa T, Granger DN, Aw TY (2000) Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-alpha production and neutrophil adhesion: role of very late antigen-4/vascular cell adhesion molecule-1. Circ Res 86(12):1237-1244
78. Barrett TD, Hennan JK, Marks RM, Lucchesi BR (2002) C-reactive-protein- associated increase in myocardial infarct size after ischemia/reperfusion. J Pharmacol Exp Ther 303(3):1007-1013
79. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18):2165-2168
80. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA (2002) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105(16):1890-1896
81. Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC (2003) Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res 92(4):371-377
82. Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM (2003) C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 23(4):650-655
83. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Saito T, Manabe I, Imai Y, Nagai R (2006) C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells. Atherosclerosis 185(1):39-46
84. Uehara K, Nomura M, Ozaki Y, Fujinaga H, Ikefuji H, Kimura M, Chikamori K, Nakaya Y, Ito S (2003) High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Hear Vessel 18(2):67-74
85. Hillis GS, Flapan AD (1998) Cell adhesion molecules in cardiovascular disease: a clinical perspective. Heart 79(5):429-431
86. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ (1992) Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci 667:324-331
87. Lu HH, Sheng ZQ, Wang Y, Zhang L (2010) Levels of soluble adhesion molecules in patients with various clinical presentations of coronary atherosclerosis. Chin Med J (Engl) 123(21):3123-3126
88. Siminiak T, Dye JF, Egdell RM, More R, Wysocki H, Sheridan DJ (1997) The release of soluble adhesion molecules ICAM-1 and E-selectin after acute myocardial infarction and following coronary angioplasty. Int J Cardiol 61(2):113-118
89. Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27(11):2292-2301
90. Entman ML, Smith CW (1994) Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 28(9):1301-1311
91. Luscinskas FW, Gimbrone MA Jr (1996) Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 47:413-421
92. Muller WA (2002) Leukocyte-endothelial cell interactions in the inflammatory response. Lab Investig 82(5):521-533
93. Kubes P, Jutila M, Payne D (1995) Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95(6):2510-2519
94. Richter V, Rassoul F, Purschwitz K, Hentschel B, Reuter W, Kuntze T (2003) Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology 49(5):293-300
95. Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170(2):191-203
96. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92(2):945-951
97. Couffinhal T, Duplaa C, Moreau C, Lamaziere JM, Bonnet J (1994) Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 74(2):225-234
98. Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B (2008) Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem 41(3):126-133
99. Patti G, Chello M, Pasceri V, Colonna D, Nusca A, Miglionico M, D'Ambrosio A, Covino E, Di Sciascio G (2006) Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol 48(8):1560-1566
100. Silver MJ, Sutton JM, Hook S, Lee P, Malycky JL, Phillips ML, Ellis SG, Topol EJ, Nicolini FA (1995) Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation 92(3):492-499
101. Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161(2):851-858
102. Nah DY, Rhee MY (2009) The inflammatory response and cardiac repair after myocardial infarction. Korean Circ J 39(10):393-398